The receptor binding site of feline leukemia virus surface glycoprotein is distinct from the site involved in virus neutralization

Journal of Virology

Volumn 72, Issue 4, 1998, Pages 3268-3277

  Ramsey, I K ^a,b   Spibey, N ^b   Jarrett, O ^b  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b UNIVERSITY OF GLASGOW   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CELL SURFACE RECEPTOR; EPITOPE; NEUTRALIZING ANTIBODY; RECOMBINANT PROTEIN; VIRUS GLYCOPROTEIN;

AMINO TERMINAL SEQUENCE; ARTICLE; BINDING SITE; CELL SURFACE; FELINE LEUKEMIA VIRUS; IMMUNOBLOTTING; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; RECEPTOR BINDING; VIRUS NEUTRALIZATION;

EID: 0031901640     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.72.4.3268-3277.1998     Document Type: Article

References (48)

1. Arp, J., C. M. Ford, T. J. Palker, E. E. King, and G. A. Dekaban. 1993. Expression and immunogenicity of the entire human T cell leukaemia virus type 1 envelope protein produced in a baculovirus system. J. Gen. Virol. 74:211-222.
2. Brojatsch, J., B. S. Kristal, G. A. Viglianti, R. Khiroya, E. A. Hoover, and J. I. Mullins. 1992. Feline leukemia virus subgroup C phenotype evoloves through distinct alterations near the N terminus of the envelope surface glycoprotein. Proc. Natl. Acad. Sci. USA 89:8457-8461.
3. Devereux, J., P. Haeberle, and O. Smithies. 1984. A comprehensive set of sequence analysis programs for the VAX. Nucleic Acids Res. 12:387-395.
4. Donahue, P. R., E. A. Hoover, G. A. Beltz, N. Riedel, V. Hirsch, J. Overbaugh, and J. I. Mullins. 1988. Strong sequence conservation among horizontally transmissible, minimally pathogenic feline leukemia viruses. J. Virol. 62:722-731.
5. Einfeld, D., and E. Hunter. 1988. Oligomeric structure of a prototype retrovirus glycoprotein. Proc. Natl. Acad. Sci. USA 85:8688-8692.
6. Elder, J. H., J. S. McGee, M. Munson, R. A. Houghten, W. Kloetzer, J. L. Bittle, and C. K. Grant. 1987. Localization of neutralizing regions of the envelope gene of feline leukemia virus using anti-synthetic peptide antibodies. J. Virol. 61:8-15.
7. Ghosh, A. K., M. H. Bachmann, E. A. Hoover, and J. I. Mullins. 1992. Identification of a putative receptor for subgroup A feline leukemia virus on feline T cells. J. Virol. 66:3707-3714.
8. Hochuli, E., H. Dobeli, and A. Schacher. 1987. New metal chelate adsorbent selective for proteins and peptides containing neighbouring histidine residues. J. Chromatogr. 411:177-184.
9. Hu, S., S. G. Kosowski, and K. F. Schaaf. 1987. Expression of envelope glycoproteins of human immunodeficiency virus by an insect virus vector. J. Virol. 61:3617-3620.
10. Jameson, B. A., and H. Wolf. 1988. The antigenic index: a novel algorithm for predicting antigenic determinants. CABIOS 4:181-186.
11. Jarrett, O. 1984. Pathogenesis of feline leukaemia virus-related diseases, p. 135-154. In J. M. Goldman and O. Jarrett (ed.), Mechanisms of viral leukaemogenesis. Churchill-Livingstone, Edinburgh, United Kingdom.
12. Jarrett, O., and J. Ganiere. 1996. Comparative studies of the efficacy of a recombinant feline leukaemia virus vaccine. Vet. Rec. 138:7-11.
13. Jarrett, O., W. D. J. Hardy, M. C. Golder, and D. Hay. 1978. The frequency of occurrence of feline leukemia virus subgroups in cats. Int. J. Cancer 21:334-337.
14. Jarrett, O., H. M. Laird, and D. Hay. 1972. Restricted host range of a feline leukaemia virus. Nature 238:220-221.
15. Jarrett, O., H. M. Laird, and D. Hay. 1973. Determinants of the host range of feline leukaemia viruses. J. Gen. Virol. 20:169-175.
16. Javaherian, K., A. J. Langlois, C. McDanal, K. L. Ross, L. I. Eckler, C. L. Jellis, A. T. Profy, J. R. Rusche, D. P. Bolognesi, S. D. Putney, and T. J. Matthews. 1989. Principal neutralizing domain of the human immunodeficiency virus type 1 envelope glycoprotein. Proc. Natl. Acad. Sci. USA 86: 6768-6772.
17. Kawakami, T. G., G. H. Theilen, D. L. Dungworth, R. J. Munn, and S. G. Beall. 1967. C-type viral particles in plasma of cats with feline leukemia. Science 158:1049.
18. King, L. A., and R. D. Possee. 1992. The baculovirus expression system. A laboratory guide. Chapman & Hall, London, United Kingdom.
19. Lutz, H., N. Pedersen, J. Higgins, U. Hubscher, F. A. Troy, and G. H. Theilen. 1980. Humoral immune reactivity to feline leukemia virus and associated antigens in cats naturally infected with feline leukemia virus. Cancer Res. 40:3642-3651.
20. Mackey, L., W. Jarrett, O. Jarrett, and H. M. Laird. 1975. Anemia associated with feline leukemia virus infection in cats. J. Natl. Cancer Inst. 54: 209-217.
21. Madewell, B. R., and O. Jarrett. 1983. Recovery of feline leukaemia virus from non-viraemic cats. Vet. Rec. 112:339-342.
22. Neil, J. C., R. Fulton, M. Rigby, and M. Stewart. 1991. Evolution of pathogenic and oncogenic variants of feline leukaemia virus. Curr. Top. Microbiol. Immunol. 171:67-93.
23. Nick, S., J. Klaws, K. Friebel, C. Birr, G. Hunsmann, and H. Bayer. 1990. Virus neutralising and enhancing epitopes characterised by synthetic oligopeptides derived from the feline leukaemia virus glycoprotein sequence. J. Gen. Virol. 71:77-83.
24. Nunberg, J. H., M. E. Williams, and M. A. Innis. 1984. Nucleotide sequences of the envelope genes of two isolates of feline leukemia virus subgroup B. J. Virol. 49:629-632.
25. Onions, D., O. Jarrett, N. Testa, F. Frassoni, and S. Toth. 1982. Selective effect of feline leukaemia virus on early erythroid precursors. Nature 296: 156-158.
26. Overbaugh, J., N. Riedel, E. A. Hoover, and J. I. Mullins. 1988. Transduction of endogenous envelope genes by feline leukaemia virus in vitro. Nature 332:731-734.
27. Ramsey, I. K. 1993. Recombinant surface glycoproteins of feline leukaemia virus. Ph.D. thesis. University of Glasgow, Glasgow, United Kingdom.
28. Reinhart, T. A., A. K. Ghosh, E. A. Hoover, and J. I. Mullins. 1993. Distinct superinfection interference properties yet similar receptor utilization by cytopathic and noncytopathic feline leukemia viruses. J. Virol. 67:5153-5162.
29. Rickard, D. G., J. E. Post, F. deNoronha, and L. M. Barry. 1969. A transmissible virus-induced lymphocytic leukemia of the cat. J. Natl. Cancer Inst. 42:987-1014.
30. Riedel, N., E. A. Hoover, R. E. Dornsife, and J. I. Mullins. 1988. Pathogenic and host range determinants of the feline aplastic anemia retrovirus. Proc. Natl. Acad. Sci. USA 85:2758-2762.
31. Riedel, N., E. A. Hoover, P. W. Gasper, M. O. Nicolson, and J. I. Mullins. 1986. Molecular analysis and pathogenesis of the feline aplastic anemia retrovirus, FeLV-C-Sarma. J. Virol. 60:242-250.
32. Rigby, M. A. 1989. Molecular basis of the subgroup determinants of feline leukaemia virus. Ph.D. thesis. University of Glasgow, Glasgow, United Kingdom.
33. Rigby, M. A., J. L. Rojko, M. A. Stewart, G. J. Kociba, C. M. Cheney, L. J. Rezanka, L. E. Mathes, J. Hartke, O. Jarrett, and J. C. Neil. 1992. Partial dissociation of subgroup C phenotype and in vivo behaviour in feline leukaemia viruses with chimeric envelope genes. J. Gen. Virol. 73:2839-2847.
34. Russell, P. H. 1977. Neutralising antibodies in feline leukaemia virus infections. Ph.D. thesis. University of Glasgow, Glasgow, United Kingdom.
35. Russell, P. H., and O. Jarrett. 1978. The occurrence of feline leukaemia virus neutralizing antibodies in cats. Int. J. Cancer 22:351-357.
36. Russell, P. H., and O. Jarrett. 1978. The specificity of neutralizing antibodies to feline leukaemia viruses. Int. J. Cancer 21:768-778.
37. Salerno, R. A., V. M. Larson, A. H. Phelps, and M. R. Hilleman. 1979. Infection and immunization of cats with the Kawakami-Theilen strain of feline leukemia virus. Proc. Soc. Exp. Biol. Med. 160:18-23.
38. Sambrook, J., E. F. Fritsch, and T. Maniatis. 1989. Molecular cloning: a laboratory manual. 2nd ed. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y.
39. Sarma, P. S., and T. Log. 1973. Subgroup classification of feline leukemia and sarcoma viruses by viral interference and neutralization tests. Virology 54:160-169.
40. Skinner, M. A., R. Ting, A. Langlois, K. J. Weinhold, H. K. Lyerly, K. Javaherian, and T. J. Matthews. 1988. Characteristics of a neutralizing monoclonal antibody to the HIV envelope protein. AIDS Res. Hum. Retroviruses 4:187-197.
41. Spibey, N. Unpublished data.
42. Stewart, M. A., M. Warnock, A. Wheeler, N. Wilkie, J. I. Mullins, D. E. Onions, and J. C. Neil. 1986. Nucleotide sequences of a feline leukemia virus subgroup A envelope gene and long terminal repeat and evidence for the recombinational origin of subgroup B viruses. J. Virol. 58:825-834.
43. Thomsen, D. R., A. L. Meyer, and L. E. Post. 1992. Expression of feline leukaemia virus gp85 and gag proteins and assembly into virus like particles using the baculovirus expression vector system. J. Gen. Virol. 73:1819-1824.
44. Verschoor, E. J., A. L. W. van Vliet, H. F. Egberink, W. Hesselink, M. C. Horizinek, and A. de Ronde. 1993. Expression of feline immunodeficiency virus gag and env precursor proteins in Spodoptera frugeriperda cells and their use in immunodiagnosis. J. Clin. Microbiol. 31:2350-2355.
45. Volkman, L. E. 1986. The 64K envelope protein of budded Autographa californica nuclear polyhedrosis virus. Curr. Top. Microbiol. Immunol. 131: 103-118.
46. Weijer, K., G. C. M. Fons, O. Jarrett, H. Lutz, and A. D. M. E. Osterhaus. 1986. Post-exposure treatment with monoclonal antibodies in a retrovirus system: failure to protect cats against feline leukemia virus infection with virus neutralizing monoclonal antibodies. Int. J. Cancer 38:81-87.
47. Weijer, K., A. Pfauth, R. van Herwijnen, O. Jarrett, R. H. Meloen, C. Tomee, and A. D. M. E. Osterhaus. 1993. Induction of feline leukaemia virus-neutralizing antibodies by immunisation with synthetic peptides derived from the FeLV env gene. Vaccine 11:946-956.
48. Wiley, D. C., I. A. Wilson, and J. J. Skehel. 1981. Structural identification of the antibody-binding sites of Hong-Kong influenza haemagglutinin and their involvement in antigenic variation. Nature 289:373-378.